Peking Union Medical College Hospital: Multiple Myeloma trials

The registry lists 10 Multiple Myeloma studies with Peking Union Medical College Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 1 2Phase 4 4No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple MyelomaNot yet recruitingNCT07353554Not applicable
• Isa-VRD in TIE HRMMNot yet recruitingNCT07334535Phase 4
• Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney InjuryNot yet recruitingNCT05429515Phase 4
• 68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple MyelomaStatus unknownNCT05364177Early Phase 1
• Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received LenalidomideStatus unknownNCT04989140Phase 4
• A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaStatus unknownNCT04295018Phase 1
• Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM PatientsCompletedNCT04217967Phase 4
• Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple MyelomaStatus unknownNCT03711864Phase 1
• Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and LymphomaStatus unknownNCT03436342Early Phase 1
• cGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.Status unknownNCT03122327